Skip to main content
    H

    HealthEquity Inc (HQY)

    Official site

    HEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ

    $104.58
    +1.12 (+1.08%)

    Market Cap: $8.56B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    HealthEquity Inc (HQY) P/E Ratio & Valuation History

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    HealthEquity (HQY) trades at 25.7x trailing earnings and 6.4x sales. Its P/E of 25.7x is below its 5-year median of 33.3x. Its forward P/E is 19.1x. The median P/E across 6 similar companies is 38.4x.

    Current Multiples

    Its forward P/E is below its trailing P/E, which implies earnings per share about 34.6% higher over the next year. Its free cash flow yield is 5.0%.

    MultipleValue
    P/E (trailing)25.7x
    Forward P/E19.1x
    Price to sales6.4x
    Price to book4.4x
    EV/EBITDA18.1x
    Price to FCF20.0x
    EV/FCF21.6x
    PEG1.3
    FCF yield5.0%
    As of Nov 17, 2026

    Historical Medians

    Against its 10-year medians, its P/E is 36.5% below 40.5x, its P/S is 8.6% below 7.0x and its P/B is 18.9% above 3.7x.

    MultipleCurrent5-year median10-year median
    P/E25.7x33.3x40.5x
    P/S6.4x6.3x7.0x
    P/B4.4x3.3x3.7x
    Medians of month-end values through Oct 2026: 60 months (5-year) and 120 months (10-year).

    Valuation History

    Over the 10 year ends shown, its P/E ranged from 24.4x in 2025 to 81.0x in 2016. 2025 was the lowest of those years.

    Year endPriceP/EP/SP/B
    2025$91.6124.4x6.2x3.7x
    2024$95.9531.3x7.3x3.9x
    2023$66.3033.1x5.8x2.9x
    2022$61.6452.2x6.2x2.8x
    2021$44.2428.5x4.9x2.0x
    2020$69.7142.2x6.8x3.9x
    2019$74.0746.3x12.0x5.1x
    2018$59.6557.4x13.6x8.1x
    2017$46.6670.7x13.0x8.5x
    2016$40.5281.0x14.2x9.5x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About HQY

    What is HQY's forward P/E ratio?

    HealthEquity has a forward P/E ratio of 19.1x.

    Is HQY stock overvalued?

    GNG's valuation label for HQY is Fairly valued. Its P/E of 25.7x compares with a median of 38.4x across 6 similar companies.

    What is HQY's price to sales ratio?

    HealthEquity has a price to sales ratio of 6.4x.

    What is HealthEquity's average P/E ratio over 5 years?

    HealthEquity's median P/E over the last 5 years is 33.3x, from 60 month-end values through Oct 2026.

    What is HQY's PEG ratio?

    HealthEquity has a PEG ratio of 1.3.